Becker's Healthcare August 28, 2024
Physicians are increasingly comfortable prescribing weight loss drugs such as Wegovy and Zepbound as new potential uses emerge, but cost and access challenges remain persistent hurdles.
Six updates on weight loss drugs:
1. Eli Lilly is now selling single-dose vials of Zepbound for about half of its usual monthly list price through its direct-to-consumer platform LillyDirect. The drugmaker is offering a four-week supply of 2.5-milligram vials for $399 and 5-milligram single-dose vials for $549. In comparison, the list prices for GLP-1 weight loss drugs are typically about $1,000 a month.
2. Novo Nordisk CEO Lars Fruergaard Jørgensen defended the cost of Wegovy this week, arguing it will lower obesity care costs for patients and employers, NBC Nightly News reported Aug....
Today's Sponsors
Today's Sponsor